All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dr.dickshard on TikTok · 32s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dr.dickshard's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Scared of injections, but want to start TRT, you're not the only one.
  2. 0:03Most guys are nervous at first, but here's the truth.
  3. 0:06Every dude who starts says the same thing.
  4. 0:09I was worried for nothing.
  5. 0:10The needle's small.
  6. 0:11The injection takes five seconds, and once you get used to it, it's nothing.
  7. 0:15Just part of the routine.
  8. 0:16What you get in return, energy, drive, focus, confidence, you feel like yourself again, and
  9. 0:22that tiny poke is more than worth it.
  10. 0:24TRT isn't scary.
  11. 0:25Staying stuck with low testosterone, it's tickle that little follow button.
  12. 0:29For more TRT videos.

@dr.dickshard's TRT claims need more context

dr.dickshard

TikTok creator

75.9K viewsWatch on TikTok

Quick answer

TRT via injection is an FDA-approved treatment for hypogonadism, with subcutaneous and intramuscular routes both demonstrating acceptable tolerability in controlled settings. The TRAVERSE trial (Lincoff et al., 2023, NEJM) confirmed no excess major cardiovascular events in treated men, but also underscored that clinical benefit is most consistent in men with laboratory-confirmed low testosterone, not self-reported symptoms. Monitoring for erythrocytosis, fertility changes, and PSA shifts is standard of care per Endocrine Society guidelines and was not addressed in this video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @dr.dickshard's TRT claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@dr.dickshard's TRT claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@dr.dickshard's TRT claims need more context" from dr.dickshard. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: TRT via injection is an FDA-approved treatment for hypogonadism, with subcutaneous and intramuscular routes both demonstrating acceptable tolerability in controlled settings.

The reason this review is not generic is the source wording and the canonical claim label "trt testosterone replacement therapy injections trt drdickshard." In this clip, the useful excerpt is: "Scared of injections, but want to start TRT, you're not the only one." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Endocrine Society guidelines (Bhasin et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

TRT via injection is an FDA-approved treatment for hypogonadism, with subcutaneous and intramuscular routes both demonstrating acceptable tolerability in controlled settings.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • TRT via injection is an FDA-approved treatment for hypogonadism, with subcutaneous and intramuscular routes both demonstrating acceptable tolerability in controlled settings. The TRAVERSE trial (Lincoff et al., 2023, NEJM) confirmed no excess major cardiovascular events in treated men, but also underscored that clinical benefit is most consistent in men with laboratory-confirmed low testosterone, not self-reported symptoms. Monitoring for erythrocytosis, fertility changes, and PSA shifts is standard of care per Endocrine Society guidelines and was not addressed in this video.
  • The TRAVERSE trial (Lincoff et al., 2023, NEJM), the largest TRT RCT to date with 5,200+ men, found no significant increase in major cardiovascular events, partially resolving a long-standing safety debate.
  • Endocrine Society guidelines (Bhasin et al., 2018) require two separate morning testosterone measurements below 300 ng/dL plus symptoms before TRT initiation. Symptoms alone are not enough.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The TRAVERSE trial (Lincoff et al., 2023, NEJM), the largest TRT RCT to date with 5,200+ men, found no significant increase in major cardiovascular events, partially resolving a long-standing safety debate.
  • Endocrine Society guidelines (Bhasin et al., 2018) require two separate morning testosterone measurements below 300 ng/dL plus symptoms before TRT initiation. Symptoms alone are not enough.
  • Erythrocytosis (elevated hematocrit) occurs in roughly 11-18% of men on injectable TRT and requires periodic blood monitoring to manage clotting risk.
  • TRT suppresses the hypothalamic-pituitary-gonadal axis, reducing sperm production in most men. This is reversible in some cases but is a significant consideration for men who want biological children.
  • A Cochrane review (Huo et al., 2016) found testosterone's effects on mood and energy were real but modest and most consistent in men with confirmed, not suspected, hypogonadism.
  • Subcutaneous injection with a small-gauge needle is genuinely low-discomfort for most men, and patient adaptation rates are high according to Roth et al. (2019, Andrology). The needle anxiety concern raised in the video is legitimate.
  • No TikTok video, regardless of creator credentials, replaces a clinical workup. A proper pre-TRT panel includes total testosterone, LH, FSH, CBC, and PSA for men over 40.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dr.dickshard actually say?

The video is a pep talk for needle-shy guys curious about testosterone replacement therapy. The creator says "the needle's small," "the injection takes five seconds," and that every man who starts TRT says "I was worried for nothing." The payoff, according to the video, is "energy, drive, focus, confidence" and feeling "like yourself again." The implicit argument is that fear of injections is the main barrier between men and feeling better, and that the trade-off is obvious.

That framing is not wrong exactly, but it is incomplete in ways that matter. The video treats TRT as a nearly consequence-free decision gated only by needle anxiety, which is a selective picture of what the evidence actually shows. Still, the mechanics of the injection claim hold up reasonably well.

Does the science back this up?

On the needle anxiety point, yes. On the broader promise of energy, drive, and confidence from TRT, the science is more conditional than the video implies.

The 2023 TRAVERSE trial (Lincoff et al., New England Journal of Medicine) is the largest randomized controlled trial of TRT to date, enrolling over 5,200 men with hypogonadism. It found that testosterone therapy did not significantly increase major cardiovascular events compared to placebo, which settled one major safety debate. But it also reinforced that benefits are most meaningful in men who actually have clinically confirmed low testosterone, not men who simply feel tired or foggy.

On the injection mechanics, subcutaneous and intramuscular testosterone injections are genuinely well-tolerated in most patients. A review by Roth et al. (2019, Andrology) confirmed that most men adapt quickly to self-injection protocols and report low procedural discomfort over time. The "five seconds" claim is reasonable for a standard cypionate or enanthate injection.

Where the video overshoots is in promising "energy, drive, focus, confidence" as if these are guaranteed outcomes. A Cochrane review (Huo et al., 2016) found that testosterone's effects on mood and energy were modest and variable across men, particularly in those without confirmed hypogonadism.

What did they get wrong (or right)?

Credit where it is due: the needle-fear barrier is real and documented. Many men avoid TRT initiation specifically because of injection anxiety, and the creator is right that most men who start injecting adapt quickly. That part of the message is accurate and probably useful.

What is wrong, or at least misleading, is the implication that benefits are universal and essentially guaranteed. "You feel like yourself again" is not a promise the data can consistently support. TRT produces meaningful symptomatic improvement in men with clinically diagnosed hypogonadism, generally defined as total testosterone below 300 ng/dL with accompanying symptoms. For men who are borderline or symptomatic for other reasons, outcomes are much more variable.

There is also zero mention of side effects. Erythrocytosis (elevated red blood cell count) is a real and common adverse effect requiring monitoring. Fertility suppression is a significant concern for men of reproductive age. Testicular atrophy occurs in most users over time. None of that got a second of airtime. A video designed to reduce barriers to TRT has an obligation to mention what those barriers exist for in the first place.

What should you actually know?

TRT is a legitimate medical treatment for men with confirmed hypogonadism, and needle anxiety should not be the reason someone avoids a conversation with a clinician. On that narrow point, the creator's message is defensible.

But TRT is not a wellness supplement with no downside risk. Before anyone starts, a proper workup includes at minimum two morning total testosterone measurements, LH and FSH levels, a complete blood count, and a prostate-specific antigen test for men over 40. The Endocrine Society clinical guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) are explicit that TRT should not be initiated based on symptoms alone.

If you are considering TRT, the conversation should happen with a licensed clinician who can review your labs, not someone whose username is a genital pun on TikTok with 75,000 views. The injection really is simple. The decision to start is not.

  • Confirmed low testosterone on bloodwork is the starting point, not symptoms alone.
  • Side effects including erythrocytosis and fertility suppression require active monitoring.
  • Benefits on mood, energy, and cognition are real but variable and most strong in men with true hypogonadism.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

dr.dickshard · TikTok creator

75.9K views on this video

TESTOSTERONE REPLACEMENT THERAPY INJECTIONS TRT #drdickshard #trt #trtgains #trt101 #trtfamily #trttransformation #trtshots #trtshot #trtforlife #trtdays #trtcommunity #trtbeforeandafter #trtlife #

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the traverse trial (lincoff et al., 2023, nejm), the largest?

The TRAVERSE trial (Lincoff et al., 2023, NEJM), the largest TRT RCT to date with 5,200+ men, found no significant increase in major cardiovascular events, partially resolving a long-standing safety debate.

What does the video say about endocrine society guidelines (bhasin et al., 2018) require two separate?

Endocrine Society guidelines (Bhasin et al., 2018) require two separate morning testosterone measurements below 300 ng/dL plus symptoms before TRT initiation. Symptoms alone are not enough.

What does the video say about erythrocytosis (elevated hematocrit) occurs in roughly 11-18% of men on?

Erythrocytosis (elevated hematocrit) occurs in roughly 11-18% of men on injectable TRT and requires periodic blood monitoring to manage clotting risk.

What does the video say about trt suppresses the hypothalamic-pituitary-gonadal axis, reducing sperm production in most?

TRT suppresses the hypothalamic-pituitary-gonadal axis, reducing sperm production in most men. This is reversible in some cases but is a significant consideration for men who want biological children.

What does the video say about a cochrane review (huo et al., 2016) found testosterone's effects?

A Cochrane review (Huo et al., 2016) found testosterone's effects on mood and energy were real but modest and most consistent in men with confirmed, not suspected, hypogonadism.

What does the video say about subcutaneous injection with a small-gauge needle?

Subcutaneous injection with a small-gauge needle is genuinely low-discomfort for most men, and patient adaptation rates are high according to Roth et al. (2019, Andrology). The needle anxiety concern raised in the video is legitimate.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by dr.dickshard, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.